Back to search
FDAFDA · Food and drugs·Recall number Z-3191-2026

Aisys CS2 with Et Control, Datex-Ohmeda anesthesia system, Part Number 1011-9000-000

Published September 23, 2026 · Recall initiated: July 30, 2026

Summary

FDA records medical device Class II recall Z-3191-2026, published September 23, 2026 and initiated July 30, 2026. Recalling firm: Datex-Ohmeda, Inc.; Status: Ongoing; Reported quantity: 7 units; Lot: Serial Numbers: ANAS01357 ANAP00609 ANAQ00988 ANAS00586 ANAR00543 ANAP01088 ANAM00443. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Anesthesia Delivery Systems containing certain electronic gas mixer assemblies can automatically transition to Alternate O2 control. In Alternate O2 control, the system delivers 100% O2 to the breathing system enabling continued controlled or manual ventilation and initiates audible and visual alarms. When this issue occurs, anesthetic agent delivery will be interrupted and requires clinician intervention. If this is not provided, the patient may experience decreased anesthetic agent effect.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Datex-Ohmeda, Inc.
Distributor
Worldwide - US Nationwide distribution.
Lot
Serial Numbers: ANAS01357 ANAP00609 ANAQ00988 ANAS00586 ANAR00543 ANAP01088 ANAM00443
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Aisys CS2 with Et Control, Datex-Ohmeda anesthesia system, Part Number 1011-9000-000 recalled?

Yes. FDA published recall Z-3191-2026 on September 23, 2026. Reported hazard: Anesthesia Delivery Systems containing certain electronic gas mixer assemblies can automatically transition to Alternate O2 control. In Alternate O2 control, the system delivers 100% O2 to the breathing system enabling continued controlled or manual ventilation and initiates audible and visual alarms. When this issue occurs, anesthetic agent delivery will be interrupted and requires clinician intervention. If this is not provided, the patient may experience decreased anesthetic agent effect.

What should I do if I have this product?

Voluntary: Firm initiated · Letter